Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in Talis Biomedical Corp as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −3 vs. Q2 2023
- Shares held
- 740.9K
- +8.65K (+1.2%) vs. Q2 2023Converted for a 1-for-15 split
- Total value
- $4.27M
- −$996.9K (−18.9%) vs. Q2 2023
- New holders
- 4
- 9 more added
- Sold out
- 7
- 4 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLIS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $26 |
| Q3 2024 | 2 | $460.4K |
| Q2 2024 | 18 | $6.84M |
| Q1 2024 | 18 | $6.93M |
| Q4 2023 | 18 | $5.93M |
| Q3 2023 | 19 | $4.27M |
| Q2 2023 | 22 | $5.27M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 27 | $5.60M |
| Q3 2022 | 29 | $8.59M |
| Q2 2022 | 35 | $12.1M |
| Q1 2022 | 45 | $23.6M |
| Q4 2021 | 47 | $70.2M |
| Q3 2021 | 38 | $119.2M |
| Q2 2021 | 43 | $184.0M |
| Q1 2021 | 45 | $269.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Talis Biomedical Corp; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 508,323 | $2.93M | 0.02% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Greenlight Capital Inc | 149,052 | $860.0K | 0.05% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Vanguard Group Inc | 30,719 | $177.2K | 0.00% | −370−1.2% | ReducedConverted for a 1-for-15 split |
| Prelude Capital Management, LLC | 14,928 | $86.1K | 0.01% | +14,928 | New |
| Susquehanna International Group, LLP | 12,166 | $70.0K | 0.00% | +11,468+1,642.0% | AddedConverted for a 1-for-15 split |
| Geode Capital Management, LLC | 11,280 | $64.9K | 0.00% | +1,911+20.4% | AddedConverted for a 1-for-15 split |
| Citigroup Inc | 5,267 | $30.3K | 0.00% | +5,267 | New |
| BlackRock Inc. | 4,926 | $28.4K | 0.00% | −161−3.2% | ReducedConverted for a 1-for-15 split |
| Morgan Stanley | 2,261 | $13.0K | 0.00% | −1,863−45.2% | ReducedConverted for a 1-for-15 split |
| Tower Research Capital LLC (TRC) | 780 | $4.50K | 0.00% | +762+4,185.7% | AddedConverted for a 1-for-15 split |
| Deutsche Bank AG | 600 | $3.46K | 0.00% | −2,420−80.1% | ReducedConverted for a 1-for-15 split |
| Royal Bank of Canada | 281 | $2.00K | 0.00% | +271+2,710.0% | AddedConverted for a 1-for-15 split |
| Advisor Group Holdings, Inc. | 172 | $992 | 0.00% | +68+65.0% | AddedConverted for a 1-for-15 split |
| UBS Group AG | 91 | $526 | 0.00% | +89+5,150.0% | AddedConverted for a 1-for-15 split |
| Larson Financial Group LLC | 14 | $81 | 0.00% | +1+5.0% | AddedConverted for a 1-for-15 split |
| Wells Fargo & Company | 12 | $69 | 0.00% | +0+3.4% | AddedConverted for a 1-for-15 split |
| Qube Research & Technologies Ltd | 2 | $12 | 0.00% | +2 | New |
| New England Capital Financial Advisors LLC | 1 | $6 | 0.00% | +0+50.0% | AddedConverted for a 1-for-15 split |
| JPMorgan Chase & Co | 1 | $6 | 0.00% | +1 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −6,098−100.0% | Sold outConverted for a 1-for-15 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −3,660−100.0% | Sold outConverted for a 1-for-15 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −3,267−100.0% | Sold outConverted for a 1-for-15 split |
| State Street Corp | 0 | $0 | 0.00% | −3,162−100.0% | Sold outConverted for a 1-for-15 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,592−100.0% | Sold outConverted for a 1-for-15 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,857−100.0% | Sold outConverted for a 1-for-15 split |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −667−100.0% | Sold outConverted for a 1-for-15 split |